Carbon nanomaterials: a promising avenue in colorectal cancer treatment
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticle-Based Drug Delivery · Carbon and Quantum Dots Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Pavitra E et al (2021) Engineered nanoparticles for imaging and drug delivery in colorectal cancer. In Seminars in cancer biology. Elsevier, London
2. Raju GSR et al (2021) Nanomaterials multifunctional behavior for enlightened cancer therapeutics. In Seminars in cancer biology. Elsevier, London
3. Pardo J, Peng Z, Leblanc RM (2018) Cancer targeting and drug delivery using carbon-based quantum dots and nanotubes. Molecules 23(2):37810.3390/molecules23020378 ↗
4. Bray F et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–42410.3322/caac.21492 ↗
5. Boyle P, Langman MJ (2000) ABC of colorectal cancer: epidemiology. BMJ 321(Suppl S6):110.1136/sbmj.0012452 ↗
6. Rawla P, Sunkara T, Barsouk A (2019) Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol 14(2):89–103
7. Viswanath B, Kim S, Lee K (2016) Recent insights into nanotechnology development for detection and treatment of colorectal cancer. Int J Nanomed 11:2491
8. Bekmezci M et al (2023) Modified screen-printed electrochemical biosensor design compatible with mobile phones for detection of miR-141 used to pancreatic cancer biomarker. Carbon Lett 33(6):1863–187310.1007/s42823-023-00545-9 ↗
9. Mohandes F et al (2022) Magneto-fluorescent contrast agents based on carbon Dots@ Ferrite nanoparticles for tumor imaging. J Magn Magn Mater 561:16968610.1016/j.jmmm.2022.169686 ↗
10. Briolay T et al (2021) Delivery of cancer therapies by synthetic and bio-inspired nanovectors. Mol Cancer 20:1–2410.1186/s12943-021-01346-2 ↗
11. Carvalho MR et al (2019) Peptide-modified dendrimer nanoparticles for targeted therapy of colorectal cancer. Advanced Therapeutics 2(11):190013210.1002/adtp.201900132 ↗
12. Raj S et al (2021) Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy. In Seminars in cancer biology. Elsevier, London
13. Zare I et al (2024) Glycosylated nanoplatforms: From glycosylation strategies to implications and opportunities for cancer theranostics. J Control Rel 371:158–17810.1016/j.jconrel.2024.05.032 ↗
14. Ramezani Farani M et al (2023) Green synthesis of magnesium oxide nanoparticles and nanocomposites for photocatalytic antimicrobial, antibiofilm and antifungal applications. Catalysts 13(4):64210.3390/catal13040642 ↗
15. Kumar N et al (2022) Advanced metal and carbon nanostructures for medical, drug delivery and bio-imaging applications. Nanoscale 14(11):3987–401710.1039/D1NR07643D ↗
16. Zare I et al (2023) Protein-protected metal nanoclusters as diagnostic and therapeutic platforms for biomedical applications. Mater Today 66:159–19310.1016/j.mattod.2020.10.027 ↗
17. Zhang C et al (2020) Progress, challenges, and future of nanomedicine. Nano Today 35:10100810.1016/j.nantod.2020.101008 ↗
18. Yaraki MT et al (2022) Biomimetic metallic nanostructures for biomedical applications, catalysis, and beyond. Ind Eng Chem Res 61(22):7547–759310.1021/acs.iecr.2c00285 ↗
19. Pei Z et al (2022) Current perspectives and trend of nanomedicine in cancer: a review and bibliometric analysis. J Control Release 352:211–24110.1016/j.jconrel.2022.10.023 ↗
20. de Lázaro I, Mooney DJ (2021) Obstacles and opportunities in a forward vision for cancer nanomedicine. Nat Mater 20(11):1469–147910.1038/s41563-021-01047-7 ↗
21. Azarian M et al (2024) Functionalized porphysomes and porphyrin-based nanomaterials for cancer therapy. In Functionalized nanomaterials for cancer research. Elsevier, London, pp 329–34410.1016/B978-0-443-15518-5.00002-1 ↗
22. Quader S, Kataoka K, Cabral H (2022) Nanomedicine for brain cancer. Adv Drug Deliv Rev 182:11411510.1016/j.addr.2022.114115 ↗
23. Tangsiri M et al (2024) Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT). Biomed Pharmacother 170:11597310.1016/j.biopha.2023.115973 ↗
24. Tavakkoli Yaraki M et al (2023) Graphene-based nanocomposites for cancer cell detection, in graphene-based nanocomposite sensors: detection to diagnosis. R Soc Chem 60:289–318
25. Georgakilas V et al (2015) Broad family of carbon nanoallotropes: classification, chemistry, and applications of fullerenes, carbon dots, nanotubes, graphene, nanodiamonds, and combined superstructures. Chem Rev 115(11):4744–482210.1021/cr500304f ↗
26. Patelkd SR, Kim H (2019) Carbon-basednanomaterialsasanemergingplatformfortheranostics. Mater Horiz 6:434–46910.1039/C8MH00966J ↗
27. Gutierrez-Stampa MA et al (2020) Impact of the faecal immunochemical test on colorectal cancer survival. BMC Cancer 20(1):1–1110.1186/s12885-020-07074-y ↗
28. Ordikhani F et al (2015) Physicochemical and biological properties of electrodeposited graphene oxide/chitosan films with drug-eluting capacity. Carbon 84:91–10210.1016/j.carbon.2014.11.052 ↗
29. Holme Ø et al (2014) Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA 312(6):606–61510.1001/jama.2014.8266 ↗
30. Cross A et al (2019) Whole colon investigation versus flexible sigmoidoscopy for suspected colorectal cancer based on presenting symptoms and signs: a multicentre cohort study. Br J Cancer 120(2):154–16410.1038/s41416-018-0335-z ↗
31. Manfredi L (2021) Endorobots for colonoscopy: design challenges and available technologies. Front Robot AI 8:70545410.3389/frobt.2021.705454 ↗
32. Selby JV et al (1992) A case–control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326(10):653–65710.1056/NEJM199203053261001 ↗
33. Mármol I, Sánchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ (2017) Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci 18(1):19710.3390/ijms18010197 ↗
34. Krasteva N, Georgieva M (2022) Promising therapeutic strategies for colorectal cancer treatment based on nanomaterials. Pharmaceutics 14(6):121310.3390/pharmaceutics14061213 ↗
35. Adel M et al (2023) Nanodiamonds for tissue engineering and regeneration. J Drug Del Sci Technol 90:10513010.1016/j.jddst.2023.105130 ↗
36. Farani MR et al (2020) PEGylation of graphene/iron oxide nanocomposite: assessment of release of doxorubicin, magnetically targeted drug delivery and photothermal therapy. Appl Nanosci 10(4):1205–121710.1007/s13204-020-01255-8 ↗
37. Eivazzadeh-Keihan RSZ, Lalebeigi F, Naderi N, Panahi L, Ganjali F, Mahdian S, Saadatidizaji Z, Mahdavi M, Chidar E, Soleimani E, Ghaee A, Maleki A, Zare I (2024) Effects of mechanical properties of carbon-based nanocomposites on scaffolds for tissue engineering applications: a comprehensive review. Nanoscale Adv 6:337–36610.1039/D3NA00554B ↗
38. Ramezani Farani M et al (2019) Extending the application of a magnetic PEG three-part drug release device on a graphene substrate for the removal of Gram-positive and Gram-negative bacteria and cancerous and pathologic cells. Drug Des Develop Therapy 2019:1581–159110.2147/DDDT.S181090 ↗
39. Kong B et al (2022) Carbon dots as nanocatalytic medicine for anti-inflammation therapy. J Colloid Interface Sci 611:545–55310.1016/j.jcis.2021.12.107 ↗
40. Raya I et al (2021) A review of gas sensors based on carbon nanomaterial. Carbon Lett 2021:1–26
41. Azizi-Lalabadi M et al (2020) Carbon nanomaterials against pathogens; the antimicrobial activity of carbon nanotubes, graphene/graphene oxide, fullerenes, and their nanocomposites. Adv Coll Interface Sci 284:10225010.1016/j.cis.2020.102250 ↗
42. Zare I et al (2024) Hydrogel-integrated graphene superstructures for tissue engineering: from periodontal to neural regeneration. Carbon 2024:11897010.1016/j.carbon.2024.118970 ↗
43. Zainal MT et al (2023) Zero-dimensional model for the prediction of carbon nanotube (CNT) growth region in heterogeneous methane-flame environment. Carbon Lett 33(7):2199–221010.1007/s42823-023-00579-z ↗
44. Hampel S et al (2008) Carbon nanotubes filled with a chemotherapeutic agent: a nanocarrier mediates inhibition of tumor cell growth. Nanomedicine 3:175–18210.2217/17435889.3.2.175 ↗
45. Farokh A et al (2023) Assessment of synthesized chitosan/halloysite nanocarrier modified by carbon nanotube for pH-sensitive delivery of curcumin to cancerous media. Int J Biol Macromol 237:12393710.1016/j.ijbiomac.2023.123937 ↗
46. Lee Y, Geckeler KE (2012) Cellular interactions of a water-soluble supramolecular polymer complex of carbon nanotubes with human epithelial colorectal adenocarcinoma cells. Macromol Biosci 12(8):1060–106710.1002/mabi.201200085 ↗
47. Zhou M et al (2014) Design of microencapsulated carbon nanotube-based microspheres and its application in colon targeted drug delivery. Drug Delivery 21(2):101–10910.3109/10717544.2013.834413 ↗
48. Levi-Polyachenko NH et al (2009) Rapid photothermal intracellular drug delivery using multiwalled carbon nanotubes. Mol Pharm 6(4):1092–109910.1021/mp800250e ↗
49. Zakaria AB et al (2015) Nanovectorization of TRAIL with single wall carbon nanotubes enhances tumor cell killing. Nano Lett 15(2):891–89510.1021/nl503565t ↗
50. Zare I et al (2023) DNA hydrogels and nanogels for diagnostics, therapeutics, and theragnostics of various cancers. Nanoscale 15(26):10882–1090310.1039/D3NR00425B ↗
51. Ertas YN et al (2021) Nanoparticles for targeted drug delivery to cancer stem cells: a review of recent advances. Nanomaterials 11(7):110.3390/nano11071755 ↗
52. Arbogast JW et al (1991) Photophysical properties of sixty atom carbon molecule (C60). J Phys Chem 95(1):11–1210.1021/j100154a006 ↗
53. Fernandes NB et al (2022) Fullerenes for the treatment of cancer: an emerging tool. Environ Sci Pollut Res 29(39):58607–5862710.1007/s11356-022-21449-7 ↗
54. Yin L et al (2016) Effects of C60 on the photochemical formation of reactive oxygen species from natural organic matter. Environ Sci Technol 50(21):11742–1175110.1021/acs.est.6b04488 ↗
55. Fan Y et al (2015) Extremely high brightness from polymer-encapsulated quantum dots for two-photon cellular and deep-tissue imaging. Sci Rep 5(1):1–7
56. Holliger P, Hudson PJ (2005) Engineered antibody fragments and the rise of single domains. Nat Biotechnol 23(9):1126–113610.1038/nbt1142 ↗
57. Yano S et al (2011) Current states and future views in photodynamic therapy. J Photochem Photobiol C 12(1):46–6710.1016/j.jphotochemrev.2011.06.001 ↗
58. Vajtai R (2013) Springer handbook of nanomaterials. Springer, London10.1007/978-3-642-20595-8 ↗
59. Lee P-C et al (2016) Development of a controlled-release drug delivery system by encapsulating oxaliplatin into SPIO/MWNT nanoparticles for effective colon cancer therapy and magnetic resonance imaging. Biomater Sci 4(12):1742–175310.1039/C6BM00444J ↗
60. Oberlin A, Endo M, Koyama T (1976) Filamentous growth of carbon through benzene decomposition. J Cryst Growth 32(3):335–34910.1016/0022-0248(76)90115-9 ↗
61. Zhbanov A, Pogorelov E, Chang Y (2010) Van der Waals interaction between two crossed carbon nanotubes. ACS Nano 4:5937–594510.1021/nn100731u ↗
62. Li C, Chou T-W (2003) Elastic moduli of multi-walled carbon nanotubes and the effect of van der Waals forces. Compos Sci Technol 63(11):1517–152410.1016/S0266-3538(03)00072-1 ↗
63. Avouris P et al (1999) Carbon nanotubes: nanomechanics, manipulation, and electronic devices. Appl Surf Sci 141(3–4):201–20910.1016/S0169-4332(98)00506-6 ↗
64. Niyogi S, Bhowmik BP, Sen R, Itkis ME, Haddon RC et al (2002) Chemistry of single-walled carbon nanotubes. Acc Chem Res 35:110510.1021/ar010155r ↗
65. Sun Y-P et al (2002) Functionalized carbon nanotubes: properties and applications. Acc Chem Res 35(12):1096–110410.1021/ar010160v ↗
66. Hwang J-Y et al (2013) Biofunctionalized carbon nanotubes in neural regeneration: a mini-review. Nanoscale 5(2):487–49710.1039/C2NR31581E ↗
67. Georgakilas V et al (2002) Organic functionalization of carbon nanotubes. J Am Chem Soc 124(5):760–76110.1021/ja016954m ↗
68. Hirsch A (2002) Functionalization of single-walled carbon nanotubes. Angew Chem Int Ed 41(11):1853–185910.1002/1521-3773(20020603)41:11<1853::AID-ANIE1853>3.0.CO;2-N ↗
69. Klumpp C et al (2006) Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics. Biochim Biophys Acta (BBA) Biomembr 1758(3):404–41210.1016/j.bbamem.2005.10.008 ↗
70. Zhang X et al (2021) Cation modulation of cobalt sulfide supported by mesopore-rich hydrangea-like carbon nanoflower for oxygen electrocatalysis. ACS Appl Mater Interfaces 13(16):18683–1869210.1021/acsami.1c00579 ↗
71. Alam A-M et al (2015) Synthesis of carbon quantum dots from cabbage with down-and up-conversion photoluminescence properties: excellent imaging agent for biomedical applications. Green Chem 17(7):3791–379710.1039/C5GC00686D ↗
72. Kang S et al (2017) Gold nanoparticle/graphene oxide hybrid sheets attached on mesenchymal stem cells for effective photothermal cancer therapy. Chem Mater 29(8):3461–347610.1021/acs.chemmater.6b05164 ↗
73. Yang K et al (2013) Behavior and toxicity of graphene and its functionalized derivatives in biological systems. Small 9(9–10):1492–150310.1002/smll.201201417 ↗
74. Chen J et al (2023) A graphene-based highly sensitive aptasensor for the detection of lung cancer marker CA125. Carbon Lett 33(6):1811–181710.1007/s42823-023-00560-w ↗
75. Zhang C et al (2023) Synergistic effect of novel ionic liquid/graphene complex on the flame retardancy of epoxy nanocomposites. Carbon Lett 33(2):501–51610.1007/s42823-022-00440-9 ↗
76. Mohanty A (2023) Utilization of graphene to attain sustainability in mine methodology: a review. Carbon Lett 33(3):641–66010.1007/s42823-023-00476-5 ↗
77. Taheriazam A et al (2023) Graphene oxide nanoarchitectures in cancer biology: nano-modulators of autophagy and apoptosis. J Control Rel 354:503–52210.1016/j.jconrel.2023.01.028 ↗
78. Dong Y et al (2010) Extraction of electrochemiluminescent oxidized carbon quantum dots from activated carbon. Chem Mater 22(21):5895–589910.1021/cm1018844 ↗
79. Liu L et al (2021) Recent progress of graphene oxide-based multifunctional nanomaterials for cancer treatment. Cancer Nanotechnol 12:1–3110.1186/s12645-021-00087-7 ↗
80. Yu W et al (2020) Progress in the functional modification of graphene/graphene oxide: a review. RSC Adv 10(26):15328–1534510.1039/D0RA01068E ↗
81. Chua CK, Pumera M (2013) Covalent chemistry on graphene. Chem Soc Rev 42(8):3222–323310.1039/c2cs35474h ↗
82. Zhang B et al (2017) Recent developments of phototherapy based on graphene family nanomaterials. Curr Med Chem 24(3):268–29110.2174/0929867323666161019141817 ↗
83. Liu Z et al (2008) Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc Natl Acad Sci 105(5):1410–141510.1073/pnas.0707654105 ↗
84. Wang Y et al (2011) Graphene and graphene oxide: biofunctionalization and applications in biotechnology. Trends Biotechnol 29(5):205–21210.1016/j.tibtech.2011.01.008 ↗
85. Lim D-J et al (2014) Carbon-based drug delivery carriers for cancer therapy. Arch Pharmacal Res 37:43–5210.1007/s12272-013-0277-1 ↗
86. Xu M et al (2016) Improved in vitro and in vivo biocompatibility of graphene oxide through surface modification: poly(acrylic acid)-functionalization is superior to PEGylation. ACS Nano 10(3):3267–328110.1021/acsnano.6b00539 ↗
87. Patel KD, Singh RK, Kim H-W (2019) Carbon-based nanomaterials as an emerging platform for theranostics. Mater Horiz 6(3):434–46910.1039/C8MH00966J ↗
88. Petrone A, Goings JJ, Li X (2016) Quantum confinement effects on optical transitions in nanodiamonds containing nitrogen vacancies. Phys Rev B 94(16):16540210.1103/PhysRevB.94.165402 ↗
89. Pichot V et al (2013) Understanding ultrafine nanodiamond formation using nanostructured explosives. Sci Rep 3(1):215910.1038/srep02159 ↗
90. Vaijayanthimala V et al (2015) Nanodiamond-mediated drug delivery and imaging: challenges and opportunities. Expert Opin Drug Deliv 12(5):735–74910.1517/17425247.2015.992412 ↗
91. Esmailzadeh F et al (2024) Bonding states of gold/silver plasmonic nanostructures and sulfur-containing active biological ingredients in biomedical applications: a review. Phys Chem Chem Phys 2024:1
92. Reina G et al (2015) Rhodamine/nanodiamond as a system model for drug carrier. J Nanosci Nanotechnol 15(2):1022–102910.1166/jnn.2015.9736 ↗
93. Zhu Y et al (2012) The biocompatibility of nanodiamonds and their application in drug delivery systems. Theranostics 2(3):30210.7150/thno.3627 ↗
94. Huang H et al (2007) Active nanodiamond hydrogels for chemotherapeutic delivery. Nano Lett 7(11):3305–331410.1021/nl071521o ↗
95. Smart S et al (2006) The biocompatibility of carbon nanotubes. Carbon 44(6):1034–104710.1016/j.carbon.2005.10.011 ↗
96. Aoki K, Saito N (2020) Biocompatibility and carcinogenicity of carbon nanotubes as biomaterials. Nanomaterials 10(2):26410.3390/nano10020264 ↗
97. Zaid MHM et al (2024) Biocompatibility and cytotoxicity studies of zero-dimensional carbon nanomaterials. In Zero-dimensional carbon nanomaterials. Elsevier, London, pp 611–64010.1016/B978-0-323-99535-1.00019-6 ↗
98. Yaraki MT et al (2023) Graphene-based nanocomposites for cancer cell detection10.1039/BK9781837671847-00289 ↗
99. Ramezani Farani M et al (2024) Functionalized carbon nanostructures for medical diagnosis. In Handbook of functionalized carbon nanostructures: from synthesis methods to applications. Springer, London, pp 1–3310.1007/978-3-031-14955-9_59-1 ↗
100. Murjani BO et al (2022) Carbon nanotubes in biomedical applications: current status, promises, and challenges. Carbon Lett 32(5):1207–122610.1007/s42823-022-00364-4 ↗